LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 44 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $136,000 | – | 18,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |